10-Q: Medicale Corp. Reports Q1 2025 Results: Net Loss Decreases Amid Focus on Capital Raising

Medicale Corp. reports a decreased net loss for the quarter ended December 31, 2024, while continuing efforts to raise capital and commence operations.

Summary

• Medicale Corp. reported its financial results for the quarter ended December 31, 2024.
• The company's net loss decreased to $12,680 from $19,307 in the same period last year.
• Operating expenses decreased by 43% to $10,995.
• The company had cash of $159 as of December 31, 2024.
• The company has a working capital deficiency of $18,028.
• The company is focused on raising capital to fund operating expenses.
• The company has not yet commenced operations as of the date of the report.
• The company has convertible notes payable totaling $93,585 as of December 31, 2024.
• There is substantial doubt about the company's ability to continue as a going concern.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the company's lack of operations, going concern uncertainty, and reliance on capital raising, although the reduced net loss is a minor positive.

Positives

• The net loss decreased by $6,627, or 34%, compared to the same period last year.
• Operating expenses decreased by 43% due to lower audit and review fees, transfer agent fees, and filing fees.

Negatives

• The company has not yet commenced operations.
• The company has a working capital deficiency of $18,028.
• The company has an accumulated deficit of $188,525.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company's disclosure controls and procedures were not effective as of December 31, 2024.

Risks

• The company's ability to continue as a going concern is uncertain.
• The company is dependent on raising additional capital to fund operating expenses.
• The company has not yet commenced operations and may not be successful in its business operations.
• The company's disclosure controls and procedures were not effective as of December 31, 2024.
• The company has significant convertible note liabilities that could dilute existing shareholders.

Future Outlook

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses and intends to position itself to raise additional funds through the capital markets.

Management Comments

• Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses.
• The Company intends to position itself so that it will be able to raise additional funds through the capital markets.

Industry Context

Given the company's early stage and lack of revenue, it is difficult to compare it to established players in the dietary supplement or consulting services industries; the company's focus on raising capital and commencing operations is typical for a startup.

Comparison to Industry Standards

• It is difficult to compare Medicale Corp.'s performance to industry standards due to its early stage and lack of revenue.
• Many early-stage companies in the dietary supplement or consulting services industries rely on venture capital or angel investors for funding, similar to Medicale Corp.'s stated intention to raise capital.
• The company's negative working capital and accumulated deficit are common for startups that have not yet achieved profitability.

Management Changes

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern uncertainty and reliance on capital raising.
• Employees (if any) face job security risks due to the company's financial instability.
• Potential customers face uncertainty regarding the availability of the company's products or services.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• The company intends to position itself so that it will be able to raise additional funds through the capital markets.
• The company plans to offer consulting services and distribution of dietary supplements.

Key Dates

Keywords

financial statements, convertible notes, going concern, net loss, operating expenses, capital raising, Medicale Corp, 10-Q